SNORD76, a box C/D snoRNA, acts as a tumor suppressor in glioblastoma

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Chen, Luyue ^a,b,c   Han, Lei ^a,b,c   Wei, Jianwei ^a,b,c   Zhang, Kailiang ^a,b,c   Shi, Zhendong ^a,b,c   Duan, Ran ^c,d   Li, Shouwei ^c,e   Zhou, Xuan ^a,b,c   Pu, Peiyu ^a,b,c   Zhang, Jianning ^a,b,c   Kang, Chunsheng ^a,b,c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Chinese Glioma Cooperative Group (CGCG)   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAS5 LONG NON-CODING RNA, HUMAN; LONG UNTRANSLATED RNA;

ANIMAL; CANCER TRANSPLANTATION; CELL PROLIFERATION; GENETICS; GLIOBLASTOMA; HUMAN; NUDE MOUSE; PATHOLOGY; S PHASE CELL CYCLE CHECKPOINT; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; HUMANS; MICE, NUDE; NEOPLASM TRANSPLANTATION; RNA, LONG NONCODING; S PHASE CELL CYCLE CHECKPOINTS; TUMOR BURDEN;

EID: 84923777453     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08588     Document Type: Article

References (35)

1. Lestrade, L. & Weber, M. J. snoRNA-LBME-db, a comprehensive database of human H/ACA and C/D box snoRNAs. Nucleic Acids Res 34, D158-62 (2006).
2. Makarova, J. A. & Kramerov, D. A. SNOntology: Myriads of novel snoRNAs or just a mirage? BMC Genomics 12, 543 (2011).
3. Williams, G. T. & Farzaneh, F. Are snoRNAs and snoRNA host genes new players in cancer? Nat. Rev. Cancer 12, 84-88 (2012).
4. Kiss, T. Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Cell 109, 145-148 (2002).
5. Henras, A. K., Dez, C. & Henry, Y. RNA structure and function in C/D and H/ ACA s(no)RNPs. Curr. Opin. Struct. Biol. 14, 335-343 (2004).
6. Kiss, T. Small nucleolar RNA-guided post-transcriptional modification of cellular RNAs. EMBO J 20, 3617-3622 (2001).
7. Liao, J. et al. Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol. Cancer 9, 198 (2010).
8. Mei, Y.-P. et al. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene 31, 2794-2804 (2012).
9. Dong, X. Y. et al. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum. Mol. Genet. 17, 1031-1042 (2007).
10. Dong, X.-Y. et al. Implication of snoRNA U50 in human breast cancer. J Genet Genomics 36, 447-454 (2009).
11. Su, H. et al. Elevated snoRNA biogenesis is essential in breast cancer. Oncogene 33, 1348-1358 (2014).
12. Valleron, W. et al. Specific small nucleolar RNA expression profiles in acute leukemia. Leukemia 26, 2052-2060 (2012).
13. Liuksiala, T. et al. Overexpression of SNORD114-3 marks acute promyelocytic leukemia. Leukemia 28, 233-236 (2014).
14. Chang, L.-S., Lin, S.-Y., Lieu, A.-S. & Wu, T.-L. Differential expression of human 5S snoRNA genes. Biochem Biophys Res Commun 299, 196-200 (2002).
15. Furnari, F. B. et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21, 2683-2710 (2007).
16. Bondy, M. L. et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113, 1953-1968 (2008).
17. Meyer, M. A. Malignant gliomas in adults. N. Engl. J. Med. 359, 1850-1850 (2008).
18. Chinot, O. L. et al. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N. Engl. J. Med. 370, 709-722 (2014).
19. Giovagnoli, A. R., Silvani, A., Colombo, E. & Boiardi, A. Facets and determinants of quality of life in patients with recurrent high grade glioma. J. Neurol. Neurosurg. Psychiatr. 76, 562-568 (2005).
20. Zhang, J.-X. et al. HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro Oncol 15, 1595-1603 (2013).
21. Zhang, Z. et al.Negative regulation of lncRNA GAS5 bymiR-21. Cell Death Differ. 20, 1558-1568 (2013).
22. Giacinti, C. & Giordano, A. RB and cell cycle progression. Oncogene 25, 5220-5227 (2006).
23. Zhang, H. S. et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101, 79-89 (2000).
24. Pasquinelli, A. E. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13, 271-282 (2012).
25. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
26. Wapinski, O. & Chang, H. Y. Long noncoding RNAs and human disease. Trends Cell Biol. 21, 354-361 (2011).
27. Yoshihama, M., Nakao, A. & Kenmochi, N. snOPY: a small nucleolar RNA orthological gene database. BMC Res Notes 6, 426 (2013).
28. Wang, K. C. & Chang, H. Y. Molecular Mechanisms of Long Noncoding RNAs. Mol. Cell 43, 904-914 (2011).
29. Askarian-Amiri, M. E. et al. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA 17, 878-891 (2011).
30. Kastan, M. B. & Bartek, J. Cell-cycle checkpoints and cancer. Nature 432, 316-323 (2004).
31. Sherr, C. J. Cancer cell cycles. Science 274, 1672-1677 (1996).
32. Schwartz, S. et al. Transcriptome-wide mapping reveals widespread dynamicregulated pseudouridylation of ncRNA and mRNA. Cell 159, 148-162 (2014).
33. Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3, 1101-1108 (2008).
34. Zhou, X. et al. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab. Invest. 90, 144-155 (2010).
35. Chen, L. et al. A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo. Oncol Rep 31, 1573-1580 (2014).